Audio Sources - Full Text Articles

Eli Lilly“s COVID drug bebtelovimab not currently authorized in U.S., says FDA


An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar

The U.S. Food and Drug Administration said on Wednesday Eli Lilly and Co’s (LLY.N) COVID-19 drug bebtelovimab is not currently authorized for emergency use in the country as it is not expected to neutralize the dominant BQ.1 and BQ.1.1 subvariants of Omicron.